A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and......
The Oxford University COVID-19 vaccine undergoing Phase III clinical trials with British pharma giant AstraZeneca is doing 'everything expected' which means good news in the fight against the......
Vital health parameters of the two volunteers, who have been administered the Oxford COVID-19 vaccine candidate at a medical college in Pune as part of the phase II clinical trial, are normal, a......
United States President Donald Trump on Sunday (local time) expressed confidence that a vaccine for coronavirus could be available by the end of the year. "I think we'll have a vaccine by the end......